RYR2 and catecholaminergic polymorphic ventricular tachycardia: In a study using a knock-in mouse model carrying a human CPVT-RyR2 mutation (R2475S), dantrolene inhibited CPVT-related tachycardia (Kobayashi et al., 2010).